MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

+ data and comment +, page-2

  1. 22,691 Posts.
    I forgot to mention that I bought shares @ $1.15.

    Obesity drug AOD9604:
    Patients will be enrolled for the all important Phase IIb trial to start in October and spread over four hospitals.

    Duration: three months only. Just about every man and his dog has applied for enrolment so there shouldn't be any hold-ups.

    This drug could be of great importance.

    Gerry

 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.